investorscraft@gmail.com

Intrinsic Value of Intercept Pharmaceuticals, Inc. (ICPT)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %9.6NaN
Revenue, $286NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m354NaN
Operating income, $m-68NaN
EBITDA, $m-66NaN
Interest expense (income), $mNaN
Earnings before tax, $m281NaN
Tax expense, $m59NaN
Net income, $m222NaN

BALANCE SHEET

Cash and short-term investments, $m491NaN
Total assets, $m554NaN
Adjusted assets (=assets-cash), $m63NaN
Average production assets, $m13751NaN
Working capital, $m310NaN
Total debt, $m333NaN
Total liabilities, $m461NaN
Total equity, $m93NaN
Debt-to-equity ratio3.574NaN
Adjusted equity ratio-4.590NaN

CASH FLOW

Net income, $m222NaN
Depreciation, amort., depletion, $m3NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-27NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m-26NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m310
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount